Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
Search
Advanced Search
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Page Path

Erratum

Erratum to ‘MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”' [Clin Mol Hepatol 2025;31:e128-e133]

Ying Wang1,2, Shengfeng Wang3,4, Xiude Fan2,5, Jiajun Zhao1,2,5orcid, Yongfeng Song2,6orcid
Clinical and Molecular Hepatology 2026;32(3):1472-1472.
Published online: July 1, 2026

1Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China

2Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong First Medical University, Jinan, Shandong, China

3Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Haidian District, Beijing, China

4Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Haidian District, Beijing, China

5Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

6Department of Endocrinology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Corresponding author : Jiajun Zhao, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 105#, Jiefang Road, Jinan, Shandong 250021, China. Tel: 86-531-55865765, Fax: +86-531-86942457, E-mail: jjzhao@sdu.edu.cn
Yongfeng Song, Department of Endocrinology, Central Hospital Affiliated to Shandong First Medical University, 105#, Jiefang Road, Jinan, Shandong 250021, China. Tel: 86-531-55865765, Fax: +86-531-86942457, E-mail: syf198506@163.com

Copyright © 2026 by The Korean Association for the Study of the Liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 304 Views
  • 9 Download
prev

Full Article

Download PDF Download PDF
This corrects the article "MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”" on page e128.
In the article entitled “MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”” the affiliation information of the corresponding author, Jiajun Zhao, was published incorrectly due to an omission during manuscript preparation.
The author’s affiliations were originally listed as 2, 5. The correct affiliations should be 1, 2, 5, with the addition of the following affiliation:
1Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
The authors apologize for this error and any inconvenience it may have caused.
Before correction
Jiajun Zhao2,5
After correction
Jiajun Zhao1,2,5

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Erratum to ‘MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”' [Clin Mol Hepatol 2025;31:e128-e133]
Clin Mol Hepatol. 2026;32(3):1472-1472.   Published online July 1, 2026
DOI: https://doi.org/10.3350/cmh.2024.1008e
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
Format:
Include:
Erratum to ‘MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”' [Clin Mol Hepatol 2025;31:e128-e133]
Clin Mol Hepatol. 2026;32(3):1472-1472.   Published online July 1, 2026
DOI: https://doi.org/10.3350/cmh.2024.1008e
Close

Related articles

Erratum to ‘MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”' [Clin Mol Hepatol 2025;31:e128-e133]
Erratum to ‘MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”' [Clin Mol Hepatol 2025;31:e128-e133]
Clin Mol Hepatol : Clinical and Molecular Hepatology
Twitter

ABOUT

BROWSE ARTICLES

FOR CONTRIBUTORS

© The Korean Association for the Study of the Liver.